« Back
Home /
Val-Cit-Exatecan (TFA)

Val-Cit-Exatecan (TFA)

Item no.	HY-160756A
Manufacturer	MedChem Express
Amount	1 ea
Specific against	other
Citations	[1]Thomas A, et al. Antibody-drug conjugates for cancer therapy. Lancet Oncol. 2016 Jun;17(6):e254-e262
Smiles	CC(C)[C@H](N)C(N[C@@H](CCCNC(N)=O)C(NCOCC(N[C@@H]1C2=C3C(C(N4C3)=CC([C@](O)(C(OC5)=O)CC)=C5C4=O)=NC6=CC(F)=C(C)C(CC1)=C62)=O)=O)=O.O=C(O)C(F)(F)F
Available
Product Description	Val-Cit-Exatecan TFA is an agent-linker conjugate for ADC. Val-Cit-Exatecan TFA is composed of a DNA topoisomerase I Exatecan (HY-13631) and a cathepsin cleavable ADC linker[1].
Shipping	Room temperature
Manufacturers Applications	Cancer-programmed cell death
MolecularWeight	892.85
Clinical Information	No Development Reported
Manufacturers Research Area	Cancer
Target	Drug-Linker Conjugates for ADC
Manufacturers Target	Drug-Linker Conjugates for ADC
Isoform	Traditional Cytotoxic Agents
Manufacturers Pathway	Antibody-drug Conjugate/ADC Related
Manufacturers Product type	Reference compound

Note: The presented information and documents (Manual, Product Datasheet, Safety Datasheet and Certificate of Analysis) correspond to our latest update and should serve for orientational purpose only. We do not guarantee the topicality. We would kindly ask you to make a request for specific requirements, if necessary.

All products are intended for research use only (RUO). Not for human, veterinary or therapeutic use.

Request Data Sheet

Request product datasheet

Request safety datasheet

Simple Order Order Subscription

Amount: 1 ea

available

Request delivery time